Main Text
CNS myelin proteins and chondroitin sulfate proteoglycans (CSPGs) are wellcharacterized inhibitors of axonal growth (1) (2) (3) (4) , but genetic and pharmacological elimination of these factors elicits only a modest increase in axonal regeneration following spinal cord injury (5) . This suggests that other inhibitory molecules are present in the CNS environment. Extracellular histones have been detected in neurodegenerative diseases such as Alzheimer's disease, scrapie, and Parkinson's disease (6) (7) (8) , and histone H1 has been shown to induce microglial activation and neuronal apoptosis. It has also been reported that histones are released from apoptotic and necrotic cells following cerebral ischemia, lung injury, and myocardial infarction (7, 9) . As ischemia and cell death are key pathophysiological events in spinal cord injury, we hypothesized that levels of extracellular histones would increase in response to trauma and that these proteins may play a role in regenerative failure.
To determine whether extracellular histones are elevated following spinal cord injury, we performed T8-9 level dorsal column lesions in 9-12 weeks old 129S1/SvImJ mice (The Jackson Laboratory) and collected cerebrospinal fluid (CSF) from the injury site 24 hours later. When compared to a sham group that received laminectomy alone, histone levels were significantly higher in CSF obtained from spinal cord-injured animals (Figs. 1E&F). To provide further evidence of histone release after CNS injury, we exposed the optic nerve in adult rats and placed gelfoam on the uninjured nerve. These pre-injury gelfoam samples were extracted 48 hours later. The nerve was then reexposed and crushed and a new piece of gelfoam was placed at the injury site for 48
hours. Western blot analysis revealed that histone levels were visibly increased in the optic nerves of individual animals following injury, and overall, this increase was statistically significant (Figs. 1G&H) . We looked at histones released in gelfoam in the same animal (N=6) with (Post-ONC) and without (Pre-ONC) optic nerve crush (ONC) and have put them in Table 1 .
To assess the effects of extracellular histones on axonal growth, we then performed a series of neurite outgrowth assays. P1 rat cortical neurons were plated on monolayers of primary rat astrocytes, and treated with a mixed population of histones isolated from calf thymus (1-20 µg/ml). Neurite outgrowth was significantly reduced in a dose-dependent manner in response to histone treatment ( Fig. 1A and S1A ). This effect was not due to toxicity or the presence of other inhibitory factors, as the astrocyte monolayers were unaffected by the histones (Figs. 1B) , and histones did not induce expression of the CSPGs neurocan and brevican in astrocytes (Fig. S1B) . Using permissive substrates of Chinese hamster ovary (CHO) cells, we observed that histones inhibited neurite outgrowth in a dose-dependent manner for both cortical (Figs. 1C&D and S2) and dorsal root ganglion neurons (Fig. S3) , and that treatment with dibutyryl cyclic AMP could reverse this inhibition (Figs. 1D&S2) . In addition, when neurons were treated with fatty acid binding protein, which has a similar size and isoelectric point (but no homology) to histones, neurite outgrowth was unaffected (Figs. 1D&S2B) . This indicates that the inhibition that was observed was histone-mediated, and not due to nonspecific steric hindrance. Finally, to elucidate the contributions of specific core histones to inhibition, cortical neurons were plated in microfluidic chambers, and recombinant histones H3 and H4 were applied to the neurite compartment. Both histone H3 and H4 inhibited neurite outgrowth, with histone H3 having a more potent effect (Fig. 1I) .
Morphologically, neurites treated with either histone H3 or H4 displayed the prominent end bulbs typical of dystrophic axons (Figs. 1I', Fig. S4 ).
Previous studies have reported that the deleterious effects of extracellular histones can be attenuated by activated protein C (APC), a coagulation factor that has been shown to specifically cleave histones H3 and H4 (6) , and enhance neuroprotection in cerebral ischemia (10) . Using cortical neurons plated in microfluidic chambers, we observed that administration of APC blocked histone-mediated inhibition of neurite outgrowth ( Fig.   2A, 2B ). To determine if APC could promote axonal regeneration in vivo, APCcontaining gelfoam was applied to the injury site following ONC in rats. Retinal ganglion cell axons were anterogradely labeled with cholera toxin B-subunit (CTB) at 14 days after injury, and optic nerves were chemically cleared using the 3-DISCO technique (11) . Crush sites were identified using a novel technique, the second harmonic (Fig. 2C, 2E ). In APC-treated animals, however, we observed a significant increase in axonal regeneration beyond the site of injury (Figs. 2D, 2E ).
To elucidate the molecular mechanism underlying histone-mediated inhibition of neurite outgrowth, we treated cortical neurons with histones for 24 hours and then plated them onto permissive CHO cell monolayers in the absence of histones (14) . Neurite outgrowth was severely impaired in these neurons (Fig. S6) , which suggested that their intrinsic capacity for neuritogenesis had been altered at the molecular level by the histones. To determine if this effect involved the activation of transcription factors, we incubated cortical neurons with extracellular histones for 30 or 120 minutes and analyzed the lysates using a Panomics Transcription Factor protein array (15) . This assay revealed significant increases in eukaryotic Y-box-binding protein-1 (YB-1) in histone-treated neurons (Fig. S7) , and we subsequently demonstrated that YB-1 expression has a direct impact on neurite outgrowth, as overexpression of YB-1 in cortical neurons resulted in shorter neurites compared to controls (Fig. 3B) . We also showed that histones H3 and H4, as well as mixed histones, can induce phosphorylation of YB-1 (Fig. 3A) . In our previous experiments we demonstrated that application of histones to distal neurites is sufficient to inhibit neurite outgrowth (Figs. 1I&2A) , and this suggests that histones may induce phosphorylation of YB-1 through retrograde signaling. To test this hypothesis, the neurite compartments of microfluidic chambers were treated with histones coupled to 6 µm silicone beads, which prevents their diffusion into the somal compartment, while preserving their ability to interact with the neurites. When the histone-conjugated beads were applied to the neurites, we observed increased pYB-1 levels in the neuronal cell bodies, confirming a retrograde signal (Fig. 4C) . Interestingly, the neurites treated with the histone-conjugated beads displayed prominent varicosities (Fig. 3D2&4 , while neurites treated with unconjugated beads were unaffected (Fig. 3D1&3. ). This not only demonstrates that the beads had no toxic effects, but also provides further evidence that histones negatively affect axonal function and integrity, as these varicosities are indicative of disruptions in axonal transport and impending degeneration. Finally, to determine if retrograde induction of YB-1 phosphorylation occurs in vivo, we performed optic nerve crushes and collected the ipsilateral and contralateral retinas 48 hours later.
We observed baseline phosphorylation of YB-1 in the contralateral retina, and this was visibly increased in response to optic nerve crush (Fig. 3E ). These results demonstrate that CNS injury can induce YB-1 phosphorylation in neurons and given our data showing that histone levels are elevated following optic nerve crush (Fig. 1H) , it is highly probable that this occurs through histone-mediated retrograde signaling.
Histones lie at the very core of chromatin structure and function, but here we show that they have a very different role outside the nucleus. Histones are released into the extracellular environment following CNS injury, and they act as potent inhibitors of axonal regeneration both in vitro and in vivo. Extracellular histones produce a degree of inhibition that is comparable to that elicited by myelin-associated inhibitors and CSPGs (16, 17) , and we therefore propose that histones should be considered a third major class of inhibitory molecules within the CNS. Eliminating inhibitory factors from the CNS environment has been widely used as a strategy to enhance axonal regeneration, but the results have often been underwhelming. Triple mutant mice lacking expression of myelin-associated glycoprotein (MAG), Nogo, and oligodendrocyte myelin glycoprotein did not exhibit spontaneous regeneration of corticospinal and raphespinal axons after spinal cord injury (5) . Similarly, elimination of CSPGs through treatment with chondroitinase ABC (chABC) resulted in only modest regeneration of dorsal column and corticospinal axons (maximum of 4 mm) following dorsal column lesions (18) . The presence and persistence of extracellular histones at the site of injury could therefore account for the limited axonal regeneration that was observed in these studies.
Having established that histones inhibit axonal regeneration, we must now consider their mechanism of action, and our observation that APC can block the effects of histones provides some initial insight. Since APC functions by cleaving histones, this indicates that histone proteins are directly responsible for mediating inhibition. This is further supported by our observation that APC cannot overcome inhibition by MAG in a neurite outgrowth assay (Fig. S8) , which demonstrates that APC does not enhance growth through non-specific degradation of other proteins or effects on the neurons themselves.
Our results also show that histones induce phosphorylation of YB-1 through retrograde signaling, which suggests that this effect is receptor-mediated. Histones have been shown to activate intracellular signaling by binding to cell-surface receptors such as Tolllike receptors 2 and 4 (19), and intriguingly, there is a demonstrated connection between TLR4 and YB-1, as TLR4 expression was reduced in YB-1 heterozygous mice (20) . This raises the possibility that histones may induce the expression and phosphorylation of YB-1 within neurons by binding to TLR4.
Studies of myelin-associated inhibitors and CSPGs have shown that these molecules inhibit axonal regeneration through activation of the small GTPase RhoA (21).
We observed that extracellular histones activated RhoA in similar manner (Fig. 3F ) and they also reduced levels of p35 (Figs. 3G) , a protein that can overcome MAG-mediated inhibition by activating cyclin-dependent kinase 5 (22) . This provides evidence that the signaling pathways activated by CNS myelin, CSPGs, and histones converge at key points to mediate inhibition, and importantly, it also shows that histones can affect cytoskeletal dynamics. It has been reported that YB-1 can promote microtubule assembly (23), and so it is possible that histones may activate RhoA through phosphorylation of YB-1.
The addition of histones to the list of inhibitory molecules in the CNS reinforces the prevailing view that combinatorial therapies will be necessary to promote axonal regeneration and functional recovery following spinal cord injury. Elevation of intracellular cyclic AMP can overcome inhibition by myelin-associated inhibitors and CSPGs, and we have found that it can reverse inhibition by histones as well (24&25), which suggests that rolipram or other phosphodiesterase inhibitors could be an effective way to target all three classes of inhibitors. Histones could also be neutralized using APC, which would digest the histones within the lesion site and create a more permissive environment for regeneration. It should be noted that this treatment would not affect histones in intact cells, which means that APC would likely have minimal adverse effects in vivo. This approach could be particularly effective when used in combination with chABC and other interventions that modify the extracellular environment, such as cell transplantation. The findings presented in this study add another layer of complexity to the challenge of promoting axonal regeneration in the CNS, but they also reveal new opportunities for progress in both fundamental and translational neuroscience that could greatly advance the treatment of spinal cord injury.
Methods
Rat primary cortical or hippocampal neuron cultures -Rat primary cortical cultures were dissected from postnatal day 1 Sprague Dawley rat brains. Cortices or hippocampi were incubated for 30mins (once for hippocampi and twice for cortices) with 0.5 mg/ml papain (Sigma) in plain Neurobasal (NB) media (Invitrogen) with DNase. Papain activity was inhibited by brief incubation in soybean trypsin inhibitor (Sigma). Cell suspensions were layered on an Optiprep density gradient (Sigma) and centrifuged at 1900 x g for 15mins at room temperature.
The purified neurons were then collected at 1000 x g for 5 mins and counted.
Primary cortical neurons were diluted to 35,000 cells/ml in NB supplemented with B27, Lglutamine and antibiotics and grown for 24hours. To quantify the outgrowth we immunostained using a monoclonal anti-βIII tubulin antibody (Tuj1;Covance) and Alexa Fluor 568-conjugated anti-mouse IgG (Invitrogen). For quantification, images were taken, and the length of the longest neurite for each neuron was measured using MetaMorph software (Molecular Devices). For western blots primary neurons were lysed in radioimmunoprecipitation assay (RIPA) buffer (50mM Tris-HCl, pH 7.5; 100mM NaCl; 1 % Nonidet P-40; 0.5 % deoxycholic acid; 0.1 % SDS; 1mM EDTA) supplemented with protease and phosphatase inhibitors. After determination of protein concentration, the cell lysates were subjected to immunoblot analysis using standard procedures and visualized by enhanced chemiluminescence (ECL). Polyclonal rabbit antibodies directed against p35, phospho-YB-1 or total YB-1 were from Cell Signaling Technology Inc.
Rat primary dorsal root ganglion neurons -Rat dorsal root ganglion (DRG) neurons from
extracted from P5-P7 day old pups. The neurons were first treated with with 0.015% collagenase in Neurobasal-A media for 45 min at 37°C. This was followed by a second incubation in collagenase for 30 min at 37°C, with the addition of 0.1% trypsin and 50 µg/ml DNase I. Trypsin was inactivated with DMEM containing 10% dialyzed fetal bovine serum. The ganglia were triturated in Sato's media and counted.
Rat primary astrocytes-We prepared mixed cortical cultures from P3-P5 pups. The cortices were removed and the meninges carefully peeled away. They were treated with 0.1% trypsin and 50 µg/ml DNase I for ten minutes at 37°C. Trypsin was inactivated with DMEM containing 10% dialyzed fetal bovine serum (FBS). We triturated the tissue and strained the cell suspension which was seeded into a pre-coated PLL T75 tissue flask in the growth media of DMEM with 10%FBS. Media was replaced within 24hrs and then every 3 days until we had a confluent layer of cells (10-14 days). To enrich for astrocytes, the media was replaced with plain NB (no supplements but containing Hepes) and we shaked the culture at 200RPM at 37°C. The media and floating cells were aspirated off and we added fresh DMEM with 10%FBS and returned to the incubator overnight. The next day we would trypsinize the remaining cells for for ten minutes at 37°C, or longer depending on how the cells are lifting off the flask. Trypsin was inactivated with DMEM containing 10% dialyzed fetal bovine serum, and the astrocytes were counted.
Neurite outgrowth assay. Mono layers of permissive control or MAG-expressing Chinese hamster ovary (CHO) cells or primary astrocytes were plated on eight well chamber slides as previously described (26) . Purified P1 hippocampal, P1 cortical, P5-P6 CGN, or P5-P6 DRG rat neurons were diluted to 35,000 cells/ml in Sato's media and treated with either 1 mM dbcAMP (Calbiochem), mixed population or recombinant Histones (1-20µg/ml) or with APC (1-20µg/ml).
Neurons were incubated for 14-18 h at 37°C and immunostained using a monoclonal anti-βIII tubulin antibody (Tuj1;Covance) and Alexa Fluor 568-conjugated anti-mouse IgG (Invitrogen).
For quantification, images were taken, and the length of the longest neurite for each neuron was measured using MetaMorph software (Molecular Devices).
Microfluidic neurite outgrowth assay-Square microfluidic chambers (150 or 450 microgroove)
were purchased from Xona microfluidics. The chambers were sterilized under UV for 15mins and soaked in 70% ethanol for 2mins and allowed to air dry under a sterile TC hood. We used MatTek dishes (P50G-1.5, MatTek corp.) that we pre-coat with PLL overnight, rinse 3 times with sterile water and air dry overnight in a sterile hood. Using sterile foceps we carefully place the microfluidic chamber on the glass area of the MatTek dish, and gently apply pressure to ensure the chambers are sitting on the glass. 3 whole brain P1-2 cortices after papain enzymatic digestion and Optiprep gradient are resuspended in 200µls of NB with full supplements. We then seed 15µls of the neuronal suspension on one side of the microgroove and place in a 37°C incubator for 20mins to allow the neurons to adhere. All wells are filled with 150µls of supplemented NB. Once we observe neurites growing across the microgroove (2-3days), we then do our treatments on the neurite compartment and wait 48hrs before we add 4%
Paraformaldehyde with 4%Sucrose. We use the Neon transfection (Invitrogen) method to overexpress the plasmid YB-1.
Rho Activation Assay. Rat cortical neurons plated in 10cm 2 dishes (approximately 10 million neurons per dish) were used with a commercially available Rho Activiation Assay Kit (Millipore). The neurons were placed in plain NB media for 4hrs prior to assay. In brief, following the manufacturers protocol, we lysed the cortical neurons on ice with MLB buffer supplemented with anti-protease and anti-phosphatase cocktails (Calbiochem) and spun the lysates at 14,000 x g for 5 mins. The supernatant was collected and added to 35µls of agarose beads coupled to Rhotekin Rho Binding Domain and rocked in the cold room for 45mins, a small sample of each supernatant was not added to the beads and was used as total Rho loading controls. Beads were washed three times with MLB buffer and 20µls 2xLaemmeli buffer was added and samples were prepared for western blotting. Proteins were separated on pre-cast 4-20% gradient gels (Thermo Fisher Scientific) and transferred to nitrocellulose at 75V for 1 hr.
Membranes were successfully probed with rabbit anti-RhoA (1:1000; Cell Signaling Technology) and HRP conjugated anti-rabbit IgG (1:2000; Cell Signaling Technology).
Membranes were reacted with Pierec ECL Western Blotting Substrate or SugperSignal West
Femto Maximam Sensitivity Substrate (Thermo Fisher Scientific). Densitometirc measurements were made using NIH Image J software.
Rat optic nerve regeneration in vivo:
Optic nerve crush experiments. Adult male or female Sprague-Dawley or rats (250-280 g, approximately 8-10 weeks old) were anesthetized with isoflurane and placed in a stereotaxic frame. The right optic nerve was exposed and crushed with fine forceps for 10s. We placed gelfoam either soaked in PBS or with APC [4.1mg/ml] (Haematologic Technologies, Inc) were placed over the injury site. 3 days prior to sacrificing we label the regenerating axons with 5µls of 1mg/ml Cholera Toxin B (CTB) coupled to Alexa-488 which we intravitreally inject. Animals 
Multiphoton Image Analysis:
Images were deconvolved using AutoQuant X Software (Media Cybernetics). Deconvolved images were then analyzed using Amira Software version 6.0.1 (Thermo Scientific). Z-stacks were uploaded to create a 3D volume rendering of the crush site and labelled neurites. For samples containing more than one Z-stack, image stacks were aligned and merged using Amira's merge module. The images were then rotated to position the crush site proximal to the retina on the left with regenerated neurites growing away from the crush site towards the right. The transformed data was resampled and axes swapped such that the XY plane became the cross section along the length of the nerve. Images were cropped if needed to exclude any partial cross sections of the ends of the nerve caused by image rotation. Labelled regenerated neurites were segmented by thresholding pixels using Amira's Segmentation Editor. The volume ratio of segmented neurites over total nerve volume was measured for each sample. Study results were then normalized and plotted in a bar graph.
The ratio of segmented area over total nerve area for each cross section was normalized and plotted as area ratio per slice. Area ratio plots were created starting from the behind the crush site proximal to the retina and following along the length of the nerve for the segmented regenerated neurites. A. Primary rat cortical neurons on an astrocytic monolayer put out long neurites (black bar) but in the presence of increasing concentrations of a mixed population histone preparation (white bars), they put out dose-dependent shorter neurites as determined by β-III tubulin staining and quantified longest length by Metamorph. This bar graph is the average of three independent experiments. B. Representative images of GFAP+ astrocytic monolayers in the absence or presence of 5-20µg/ml as indicated. C. Images of β-III tubulin+ cortical neurons on a monolayer of permissive CHO cells with or without histones as indicated. D. Cortical neurons on a permissive CHO monolayer put out long neurites (black bars, Con) but in the presence of histones they put out significantly shorter neurites (white bars). 1mM dbc-AMP alone (black bar labeled dbc) can overcome the inhibitory effect of the histones (grey bars, indicated combination of dbc-AMP and Histones in concentration noted). Using a control protein Fatty Acid Binding Protein (FABP) does not affect neurite outgrowth (black and white patterned bar graphs). E. Elevated levels of Histone H3 (HIS) in the CSF fluid collected from mice with DCL are detected by western blot, compared to laminectomy (LAM) alone. E. Histone H3 levels are normalized to Albumin (ALB) and in the bar graph is the average of 5 animals (n=5 for both DCL and LAM group) with DCL where we see a significant elevation of free Histone H3 in the CSF fluid. G. Adult rats first had their optic nerves exposed and we applied gelfoam over the uninjured nerve for 48hrs (Pre-ONC1&2), subsequently removing the gelfoam into PBS with protease inhibitor cocktail, we crushed the optic nerve and applied a fresh piece of gelfoam over the injury site. We removed the gelfoam 48hrs later (Post-ONC 1&2). We found within the same animal a significant increase in HIS levels after crushing the optic nerve (Post-ONC) than prior to injury (Pre-ONC), data was graphed in H. (n=6, see Table 1 for full comparison of Pre-and Post-ONC levels of HIS). I. Using PLL-coated microfluidic chambers, cortical neurons cell bodies (CB) grow long neurites across the 450µM microgroove as detected by β-III tubulin. Treating the neurite growing compartment with either recombinant H3 or H4 Histones resulted in significantly shorter neurites, with H3 having a more potent effect. I'. Looking at an enhanced region of the H3 20µg/ml treated side, the shorter neurites appeared to have dystrophic endbulbs. All statistics were performed by ANOVA, *p<0.05 and **p<0.01, except Figure F . was unpaired t-test and H. was paired t-test.
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